These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
277 related articles for article (PubMed ID: 7660140)
21. Inhibition of the amplification reactions of blood coagulation by site-specific inhibitors of alpha-thrombin. Ofosu FA; Fenton JW; Maraganore J; Blajchman MA; Yang X; Smith L; Anvari N; Buchanan MR; Hirsh J Biochem J; 1992 May; 283 ( Pt 3)(Pt 3):893-7. PubMed ID: 1590777 [TBL] [Abstract][Full Text] [Related]
22. Inhibition of extrinsic and intrinsic thrombin generation by a novel synthetic thrombin inhibitor (Ro 46-6240), recombinant hirudin and heparin in human plasma. Gast A; Tschopp TB Blood Coagul Fibrinolysis; 1995 Sep; 6(6):553-60. PubMed ID: 7578898 [TBL] [Abstract][Full Text] [Related]
23. Direct inhibition of protein Ca by site directed thrombin inhibitors: implications in anticoagulant and thrombolytic therapy. Callas DD; Fareed J Thromb Res; 1995 Jun; 78(5):457-60. PubMed ID: 7544924 [No Abstract] [Full Text] [Related]
24. Kinetic mechanism for the interaction of Hirulog with thrombin. Parry MA; Maraganore JM; Stone SR Biochemistry; 1994 Dec; 33(49):14807-14. PubMed ID: 7993908 [TBL] [Abstract][Full Text] [Related]
25. Effect of direct thrombin inhibitors, bivalirudin, lepirudin, and argatroban, on prothrombin time and INR values. Gosselin RC; Dager WE; King JH; Janatpour K; Mahackian K; Larkin EC; Owings JT Am J Clin Pathol; 2004 Apr; 121(4):593-9. PubMed ID: 15080313 [TBL] [Abstract][Full Text] [Related]
26. The importance of enzyme inhibition kinetics for the effect of thrombin inhibitors in a rat model of arterial thrombosis. Elg M; Gustafsson D; Deinum J Thromb Haemost; 1997 Oct; 78(4):1286-92. PubMed ID: 9364999 [TBL] [Abstract][Full Text] [Related]
27. Antithrombotic effects of three thrombin inhibitors in a rat model of laser-induced thrombosis. Krupinski K; Breddin HK; Markwardt F; Haarmann W Haemostasis; 1989; 19(2):74-82. PubMed ID: 2731778 [TBL] [Abstract][Full Text] [Related]
28. Measuring direct thrombin inhibitors with routine and dedicated coagulation assays: which assay is helpful? Curvers J; van de Kerkhof D; Stroobants AK; van den Dool EJ; Scharnhorst V Am J Clin Pathol; 2012 Oct; 138(4):551-8. PubMed ID: 23010710 [TBL] [Abstract][Full Text] [Related]
29. G-Quadruplex Aptamers to Human Thrombin Versus Other Direct Thrombin Inhibitors: The Focus on Mechanism of Action and Drug Efficiency as Anticoagulants. Zavyalova E; Ustinov N; Golovin A; Pavlova G; Kopylov A Curr Med Chem; 2016; 23(21):2230-44. PubMed ID: 27183984 [TBL] [Abstract][Full Text] [Related]
30. The direct thrombin inhibitors (argatroban, bivalirudin and lepirudin) and the indirect Xa-inhibitor (danaparoid) increase fibrin network porosity and thus facilitate fibrinolysis. He S; Blombäck M; Bark N; Johnsson H; Wallén NH Thromb Haemost; 2010 May; 103(5):1076-84. PubMed ID: 20216982 [TBL] [Abstract][Full Text] [Related]
31. A screening procedure to evaluate the anticoagulant activity and the kinetic behaviour of direct thrombin inhibitors. Rupin A; Mennecier P; de Nanteuil G; Laubie M; Verbeuren TJ Thromb Res; 1995 May; 78(3):217-25. PubMed ID: 7631302 [TBL] [Abstract][Full Text] [Related]
32. Comparing direct thrombin inhibitors using aPTT, ecarin clotting times, and thrombin inhibitor management testing. Gosselin RC; King JH; Janatpour KA; Dager WE; Larkin EC; Owings JT Ann Pharmacother; 2004 Sep; 38(9):1383-8. PubMed ID: 15238620 [TBL] [Abstract][Full Text] [Related]
33. Influence of different anticoagulant agents on fibrinopeptide a generation. Tobu M; Iqbal O; Messmore HL; Ma Q; Hoppensteadt DA; Fareed J Clin Appl Thromb Hemost; 2003 Oct; 9(4):273-92. PubMed ID: 14653437 [TBL] [Abstract][Full Text] [Related]
34. Assessment of thrombin inhibitor efficacy in a novel rabbit model of simultaneous arterial and venous thrombosis. Marsh Lyle E; Lewis SD; Lehman ED; Gardell SJ; Motzel SL; Lynch JJ Thromb Haemost; 1998 Mar; 79(3):656-62. PubMed ID: 9531058 [TBL] [Abstract][Full Text] [Related]
35. Rational design of true hirudin mimetics: synthesis and characterization of multisite-directed alpha-thrombin inhibitors. Lombardi A; Nastri F; Della Morte R; Rossi A; De Rosa A; Staiano N; Pedone C; Pavone V J Med Chem; 1996 May; 39(10):2008-17. PubMed ID: 8642559 [TBL] [Abstract][Full Text] [Related]
36. Inhibition of in vitro clot growth by r-hirudin is more effective and longer sustained than by an analogous peptide. Römisch J; Stöhr HA; Stauss H; Koschinsky R; Stüber W; Pâques EP Thromb Haemost; 1994 Mar; 71(3):320-4. PubMed ID: 8029796 [TBL] [Abstract][Full Text] [Related]
37. Small-molecule direct antithrombins: argatroban. Fareed J; Jeske WP Best Pract Res Clin Haematol; 2004 Mar; 17(1):127-38. PubMed ID: 15171962 [TBL] [Abstract][Full Text] [Related]
38. Antithrombin agents: the new class of anticoagulant and antithrombotic drugs. Fareed J; Lewis BE; Callas DD; Hoppensteadt DA; Walenga JM; Bick RL Clin Appl Thromb Hemost; 1999 Oct; 5 Suppl 1():S45-55. PubMed ID: 10726036 [TBL] [Abstract][Full Text] [Related]
39. Comparative studies on the inhibitory spectrum of recombinant hirudin, DuP 714 and heparin on thrombin and factor Xa generation in biochemically defined systems. Kaiser B; Callas D; Hoppensteadt D; Mallinowska K; Fareed J Thromb Res; 1994 Mar; 73(5):327-35. PubMed ID: 8016817 [TBL] [Abstract][Full Text] [Related]
40. Pre-clinical and clinical studies on Hirulog: a potent and specific direct thrombin inhibitor. Maraganore JM Adv Exp Med Biol; 1993; 340():227-36. PubMed ID: 8154339 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]